Calliditas Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CALT and buy or sell other stocks, ETFs, and their options commission-free!

About CALT

Calliditas Therapeutics AB clinical-stage biopharmaceutical company. It engages in the identification, development, and commercialization of novel treatments in orphan indications. 

CEO
Renée Julie Elisabet Aguiar-Lucander, MBA
CEORenée Julie Elisabet Aguiar-Lucander, MBA
Employees
Employees
Headquarters
Stockholm, Stockholm
HeadquartersStockholm, Stockholm
Founded
2004
Founded2004
Employees
Employees

CALT Key Statistics

Market cap
1.07B
Market cap1.07B
Price-Earnings ratio
-23.64
Price-Earnings ratio-23.64
Dividend yield
Dividend yield
Average volume
2.49K
Average volume2.49K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$43.00
52 Week high$43.00
52 Week low
$15.25
52 Week low$15.25

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.